Streptonigrin is an antitumor antibiotic metabolite that was first published by Rao and
Cullen in 1960. It was cocrystallized from a liquid extract from Streptomyces
flocculus. This antibiotic displays a broad spectrum of activity against cancers
in the human body, and also behaves as a weak acid.
Streptonigrin causes side effects such as desruption to the bone narrow, nausea, vomiting,
diarrhea, and hair loss.
Lab name:
Common molecules
Sample provider:
Obtained courtesy of the Cambridge Structural Database
Reciprocal Net site software 0.9.1-50,
copyright (c) 2002-2009, The Trustees of Indiana University
Files and data presented via this software are property of their
respective owners.
Reciprocal Net is funded by the U.S. National Science Foundation as part of
the National Science Digital Library project.
